Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

115 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Characteristics and Treatment Patterns of Long-surviving Patients With Multiple Myeloma: Over 13 Years of Follow-up in the ConnectⓇ MM Registry.
Terebelo HR, Omel J, Wagner LI, Hardin JW, Rifkin RM, Ailawadhi S, Durie BGM, Narang M, Toomey K, Gasparetto CJ, Joshi P, Yu E, Flick ED, Jou YM, Lee HC, Abonour R, Jagannath S. Terebelo HR, et al. Among authors: narang m. Clin Lymphoma Myeloma Leuk. 2024 Nov 6:S2152-2650(24)02401-7. doi: 10.1016/j.clml.2024.11.001. Online ahead of print. Clin Lymphoma Myeloma Leuk. 2024. PMID: 39603959
Impact of lenalidomide-bortezomib-dexamethasone induction on patients with newly diagnosed multiple myeloma and renal impairment: Results from the Connect® MM Registry.
Ailawadhi S, Lee HC, Omel J, Toomey K, Hardin JW, Gasparetto CJ, Jagannath S, Rifkin RM, Durie BGM, Narang M, Terebelo HR, Joshi P, Jou YM, Mouro J, Yu E, Abonour R. Ailawadhi S, et al. Among authors: narang m. Blood Cancer J. 2024 Nov 11;14(1):198. doi: 10.1038/s41408-024-01177-6. Blood Cancer J. 2024. PMID: 39528478 Free PMC article.
A Phase II/III multicenter randomized single blind non-inferiority immunogenicity and safety study of TeddyVac™ vaccine of Human Biologicals Institute in healthy subjects of 10 years to 60 years of age.
Susarla SK, Narang M, Khandgave PN, Patnaik L, Rajapantula V, M S, Bc R, Sahoo DP, Kanakasapapathy AK. Susarla SK, et al. Among authors: narang m. Infect Dis (Lond). 2024 Oct 8:1-15. doi: 10.1080/23744235.2024.2410466. Online ahead of print. Infect Dis (Lond). 2024. PMID: 39378070
A compact ion source combining electron-impact and thermal ionization for multiple-reflection time-of-flight mass spectrometry.
Yu J, Mollaebrahimi A, San Andrés SA, Dickel T, Plaß WR, Wilsenach H, Beck S, Ge Z, Geissel H, Hornung C, Jacobs A, Kripko-Koncz G, Kwiatkowski AA, Narang M, Scheidenberger C, Sequeira J, Walls C. Yu J, et al. Among authors: narang m. Rev Sci Instrum. 2024 Aug 1;95(8):083309. doi: 10.1063/5.0213443. Rev Sci Instrum. 2024. PMID: 39212500
The Effect of Age and Other Patient Characteristics on Outcomes Among Nontransplanted Patients Who Were Treated With First-Line Lenalidomide, Bortezomib, and Dexamethasone: Results From the ConnectⓇ MM Registry.
Abonour R, Lee HC, Rifkin R, Ailawadhi S, Omel J, Hardin JW, Narang M, Toomey K, Gasparetto C, Wagner LI, Terebelo H, Mouro J, Dhanasiri S, Liu L, Yu E, Jagannath S. Abonour R, et al. Among authors: narang m. Clin Lymphoma Myeloma Leuk. 2024 Oct;24(10):e336-e343. doi: 10.1016/j.clml.2024.05.021. Epub 2024 Jun 3. Clin Lymphoma Myeloma Leuk. 2024. PMID: 39033038
115 results